MELA Sciences (MELA) Misses Q2 EPS by 66c

MELA Sciences (NASDAQ: MELA) reported Q2 EPS of ($0.97), $0.66 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $611 million versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on MELA Sciences (MELA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance